![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vivani expects to initiate the first clinical study supporting the NPM-115 program in the fourth quarter of 2024 The NPM-115 clinical program will consist of a series of studies designed to...
NPM-119 is being studied to address medication non-adherence and potentially improve tolerability issues associated with oral and injectable type 2 diabetes medications, by providing long-term...
Data Published in BMC Veterinary Research shows that OKV-119 exenatide implant reduced feline weight Felines share many pathophysiologic obesity phenotypes with humans, further supporting...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IX |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions